CONNECT WITH US
eCommerce

eCommerce

Unilever Makes 35 Million-Euro Investment in Indian R&D Centers to Develop ‘Next Generation’ Products

WWD logo

Published on

Add as a preferred source on Google
Unilever Makes 35 Million-Euro Investment in Indian R&D Centers to Develop ‘Next Generation’ Products

The consumer giant has earmarked the funds for existing projects including Liquids Lab of the Future, the Unilever Fragrance House, and AI and digital modeling platforms.

AT SPEED: Unilever is investing 35 million euros in its Mumbai and Bangalore research and development centers with the aim of accelerating the development of “next-generation” products.

The consumer giant said the new investment will help the centers bring together a wide range of capabilities from consumer insight and scientific discovery to prototyping and scale-up “in one connected environment.” It said the aim is to transform “world-class science into superior innovation at greater speed.”

Richard Slater, Unilever’s chief research and development officer, said the 35 million euros has been earmarked for projects including Liquids Lab of the Future; the Unilever Fragrance House; Advanced Manufacturing Center for soap bars; Packaging and Flexibles Design Lab, and AI and digital modeling platforms.

Unilever, he added, has already invested more than 20 million euros over the past five years to build those state-of-the-art capabilities.

As part of the new investment, Unilever will transform Mumbai into a product innovation center that will bring together “consumer insights, new measurement approaches, product and format science, packaging design, rapid prototyping and scale-up capabilities.”

Bangalore will continue to evolve as a global science, technology and partnership hub, combining application and foundational science, digital capabilities and India Foods R&D, according to Unilever.

As part of the 35 million-euro investment, the company is earmarking 5 million euros over the next five years to establish a strategic Bio-Futures Partnership, to accelerate innovation across human biology, microbiome science, biotechnology and bio-manufacturing.


Source link
Related Topics:eCommerce

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.